In New Zealand, men die on average four to five years younger than women. That gap has narrowed over the past four decades, but it hasn't closed. It persists across ethnicity, income, and geography. It's not a coincidence, and it's not primarily biological. It is, in large part, a consequence of how men engage with their health — specifically, how late they engage, and how reluctantly.
This isn't an article about blame. It's about cause and effect. Because the gap is largely preventable, and the mechanisms that produce it are well understood. Understanding them is the starting point for doing something about them.
The biology contributes less than you'd expect
Some of the mortality gap is genuinely biological. Testosterone is associated with higher rates of risk-taking behaviour, which contributes to accidental death — particularly in younger men. Oestrogen appears to offer some cardiovascular protection that men lack until later in life. Men accumulate visceral fat more readily than pre-menopausal women, increasing metabolic and cardiovascular risk.
These factors are real. They account for perhaps one to two years of the gap. They don't account for the majority of it. The primary driver is behavioural: men present to healthcare later, get diagnosed at more advanced stages, and are significantly more likely to die from conditions that are highly treatable when caught early. The gap isn't mainly about what men have — it's about what men do. Specifically, what they don't do.
The conditions doing the most damage
Cardiovascular disease is the leading cause of death in New Zealand men — accounting for roughly 30% of male deaths annually. The risk factors (high blood pressure, elevated cholesterol, central weight gain, physical inactivity, smoking, type 2 diabetes) are all modifiable and all responsive to early detection and management. The reason cardiovascular disease kills so many men isn't that treatment doesn't exist. It's that men arrive for treatment too late — or don't arrive at all until they're in an ambulance.
Prostate cancer is the most commonly diagnosed cancer in New Zealand men, with around 3,500 new diagnoses annually. Many prostate cancers are slow-growing and highly treatable when detected early. Five-year survival for localised prostate cancer is above 99%. For metastatic prostate cancer, it drops to around 30%. The difference is almost entirely a matter of when it's found.
Colorectal cancer, lung cancer, type 2 diabetes, and chronic obstructive pulmonary disease — all disproportionately affecting men — share the same pattern: significantly more treatable early, and men present late.
Five-year survival for localised prostate cancer is above 99%. For metastatic disease, it's around 30%. The difference is almost entirely when it's found.
The help-seeking gap
Men use primary care services at significantly lower rates than women across all age groups. They're less likely to attend regular check-ups, more likely to present to emergency departments as their first point of contact with the healthcare system, and more likely to delay seeking care when symptoms appear. Research consistently shows that by the time many men seek treatment for conditions like depression, cardiovascular disease, or cancer, the condition is considerably more advanced than it would be in a woman presenting with equivalent symptoms.
The reasons aren't simple. Men describe healthcare environments as feeling designed for others — the interaction style, the communication norms, the implicit expectation of expressed vulnerability. They cite concerns about exposure, about being seen as fragile or as a burden, about the loss of control that comes with accepting a sick role. These aren't character flaws. They're predictable responses to a system that, in its design and culture, hasn't fully accounted for how men actually make decisions about their health.
What actually closes the gap
The interventions that consistently improve male health outcomes share a feature: they reduce friction. They make it easier for men to access care without first having to overcome a significant psychological barrier.
Telehealth services designed specifically for men show higher uptake, earlier presentation, and better treatment adherence than traditional models. Research from comparable platforms in Australia — where Eucalyptus built the category before being acquired for approximately \$1.6 billion AUD — demonstrated that men engage with healthcare at rates approaching women's when the pathway is private, structured, and doesn't require them to articulate vulnerability in person.
The model that works meets men where they are, frames health engagement as practical self-management rather than an admission of decline, and makes the first step feel manageable rather than exposing.
The modifiable risk factors, plainly
Blood pressure, measured regularly. A substantial proportion of New Zealand men with hypertension don't know they have it — it's asymptomatic until it causes damage, and by then it's been accumulating vascular injury for years.
Cholesterol and lipids, assessed and managed. Most men who die of their first cardiac event had elevated cholesterol that was either not measured or not treated.
Blood glucose, monitored. The Ministry of Health estimates around 100,000 New Zealanders have undiagnosed type 2 diabetes. Pre-diabetes is reversible. Caught early, type 2 diabetes is manageable. Left alone, it damages blood vessels, kidneys, eyes, and nerves over years.
Body composition, tracked honestly. Central obesity is the single most predictive physical marker of metabolic and cardiovascular risk. It's also addressable.
Most men who die of their first cardiac event had elevated cholesterol that was either not measured or not treated. That's not inevitable — it's a gap in monitoring.
What to do with this
The mortality gap is produced by identifiable, modifiable causes. If you're a man in your late 30s or beyond who hasn't had a blood panel in the past two years, that's the practical starting point. Not because something is probably wrong — but because knowing your baseline is the precondition for everything else. You can't manage what you haven't measured.
A baseline blood panel — cholesterol, blood glucose, blood pressure, testosterone — is the most useful health investment a man in his 30s or 40s can make. It takes less time than most men expect.